Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mol Plant ; 15(5): 820-839, 2022 05 02.
Artículo en Inglés | MEDLINE | ID: mdl-35063660

RESUMEN

Despite serving as a major inorganic nitrogen source for plants, ammonium causes toxicity at elevated concentrations, inhibiting root elongation early on. While previous studies have shown that ammonium-inhibited root development relates to ammonium uptake and formation of reactive oxygen species (ROS) in roots, it remains unclear about the mechanisms underlying the repression of root growth and how plants cope with this inhibitory effect of ammonium. In this study, we demonstrate that ammonium-induced apoplastic acidification co-localizes with Fe precipitation and hydrogen peroxide (H2O2) accumulation along the stele of the elongation and differentiation zone in root tips, indicating Fe-dependent ROS formation. By screening ammonium sensitivity in T-DNA insertion lines of ammonium-responsive genes, we identified PDX1.1, which is upregulated by ammonium in the root stele and whose product catalyzes de novo biosynthesis of vitamin B6. Root growth of pdx1.1 mutants is hypersensitive to ammonium, while chemical complementation or overexpression of PDX1.1 restores root elongation. This salvage strategy requires non-phosphorylated forms of vitamin B6 that are able to quench ROS and rescue root growth from ammonium inhibition. Collectively, these results suggest that PDX1.1-mediated synthesis of non-phosphorylated B6 vitamers acts as a primary strategy to protect roots from ammonium-dependent ROS formation.


Asunto(s)
Compuestos de Amonio , Proteínas de Arabidopsis , Arabidopsis , Proteínas de Arabidopsis/metabolismo , Peróxido de Hidrógeno/farmacología , Estrés Oxidativo , Raíces de Plantas , Especies Reactivas de Oxígeno , Vitamina B 6/farmacología , Vitamina B 6/fisiología , Vitaminas
2.
Med Hypotheses ; 115: 103-106, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29685187

RESUMEN

Many factors are reported to be involved in the complex pathophysiological processes of autism, suggesting that there is considerable variability in the manifestations of this disease. Several interventions are used to treat this disorder. Among them, vitamin B6 is widely used to treat the symptoms observed in autism. Vitamin B6 is beneficial for about half of autistic individuals in decreasing behavioral problems. However, until now, it remains unknown why vitamin B6 is effective for this disease. Although the exact pathogenesis is not defined, it is evident that certain neurotransmitter systems are impaired in the brains of autistic patients, causing the symptoms observed in the disease. In fact, impairment of many neurotransmitter systems has been reported, including GABA, serotonin, dopamine, and noradrenalin. Furthermore, vitamin B6 is important for the synthesis of many neurotransmitters, including GABA, serotonin, dopamine, noradrenalin, histamine, glycine, and d-serine, indicating that vitamin B6 supplementation may enhance many neurotransmitter systems. Thus, vitamin B6 supplementation can treat the impaired neurotransmitter systems in a given patient, even if the actual impaired neurotransmitter systems are not defined in that patient.


Asunto(s)
Trastorno Autístico/tratamiento farmacológico , Vitamina B 6/uso terapéutico , Trastorno Autístico/fisiopatología , Dopamina/fisiología , Glicina/fisiología , Histamina/fisiología , Humanos , Modelos Neurológicos , Neurotransmisores/fisiología , Norepinefrina/fisiología , Serina/biosíntesis , Serotonina/fisiología , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/fisiología , Vitamina B 6/fisiología , Ácido gamma-Aminobutírico/fisiología
3.
Annu Rev Nutr ; 35: 33-70, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25974692

RESUMEN

Measures of B6 status are categorized as direct biomarkers and as functional biomarkers. Direct biomarkers measure B6 vitamers in plasma/serum, urine and erythrocytes, and among these plasma pyridoxal 5'-phosphate (PLP) is most commonly used. Functional biomarkers include erythrocyte transaminase activities and, more recently, plasma levels of metabolites involved in PLP-dependent reactions, such as the kynurenine pathway, one-carbon metabolism, transsulfuration (cystathionine), and glycine decarboxylation (serine and glycine). Vitamin B6 status is best assessed by using a combination of biomarkers because of the influence of potential confounders, such as inflammation, alkaline phosphatase activity, low serum albumin, renal function, and inorganic phosphate. Ratios between substrate-products pairs have recently been investigated as a strategy to attenuate such influence. These efforts have provided promising new markers such as the PAr index, the 3-hydroxykynurenine:xanthurenic acid ratio, and the oxoglutarate:glutamate ratio. Targeted metabolic profiling or untargeted metabolomics based on mass spectrometry allow the simultaneous quantification of a large number of metabolites, which are currently evaluated as functional biomarkers, using data reduction statistics.


Asunto(s)
Biomarcadores/sangre , Estado Nutricional , Deficiencia de Vitamina B 6/sangre , Vitamina B 6 , Aminoácidos/sangre , Biomarcadores/orina , Índice de Masa Corporal , Femenino , Estado de Salud , Humanos , Lactante , Recién Nacido , Inflamación , Quinurenina/sangre , Estilo de Vida , Masculino , Metaboloma , Metabolómica , Embarazo , Piridoxal/sangre , Fosfato de Piridoxal/sangre , Ácido Piridóxico/orina , Transaminasas , Vitamina B 6/sangre , Vitamina B 6/fisiología , Vitamina B 6/orina , Deficiencia de Vitamina B 6/orina
5.
Plant Physiol ; 167(1): 102-17, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25475669

RESUMEN

Vitamin B(6) (pyridoxal 5'-phosphate) is an essential cofactor of many metabolic enzymes. Plants biosynthesize the vitamin de novo employing two enzymes, pyridoxine synthase1 (PDX1) and PDX2. In Arabidopsis (Arabidopsis thaliana), there are two catalytically active paralogs of PDX1 (PDX1.1 and PDX1.3) producing the vitamin at comparable rates. Since single mutants are viable but the pdx1.1 pdx1.3 double mutant is lethal, the corresponding enzymes seem redundant. However, the single mutants exhibit substantial phenotypic differences, particularly at the level of root development, with pdx1.3 being more impaired than pdx1.1. Here, we investigate the differential regulation of PDX1.1 and PDX1.3 by identifying factors involved in their disparate phenotypes. Swapped-promoter experiments clarify the presence of distinct regulatory elements in the upstream regions of both genes. Exogenous sucrose (Suc) triggers impaired ethylene production in both mutants but is more severe in pdx1.3 than in pdx1.1. Interestingly, Suc specifically represses PDX1.1 expression, accounting for the stronger vitamin B6 deficit in pdx1.3 compared with pdx1.1. Surprisingly, Suc enhances auxin levels in pdx1.1, whereas the levels are diminished in pdx1.3. In the case of pdx1.3, the previously reported reduced meristem activity combined with the impaired ethylene and auxin levels manifest the specific root developmental defects. Moreover, it is the deficit in ethylene production and/or signaling that triggers this outcome. On the other hand, we hypothesize that it is the increased auxin content of pdx1.1 that is responsible for the root developmental defects observed therein. We conclude that PDX1.1 and PDX1.3 play partially nonredundant roles and are differentially regulated as manifested in disparate root growth impairment morphologies.


Asunto(s)
Arabidopsis/crecimiento & desarrollo , Reguladores del Crecimiento de las Plantas/fisiología , Raíces de Plantas/crecimiento & desarrollo , Vitamina B 6/fisiología , Arabidopsis/metabolismo , Arabidopsis/fisiología , Proteínas de Arabidopsis/metabolismo , Proteínas de Arabidopsis/fisiología , Liasas de Carbono-Nitrógeno , Homeostasis/fisiología , Ácidos Indolacéticos/metabolismo , Transferasas de Grupos Nitrogenados/metabolismo , Transferasas de Grupos Nitrogenados/fisiología , Fenotipo , Reguladores del Crecimiento de las Plantas/metabolismo , Vitamina B 6/biosíntesis
6.
Biomed Res Int ; 2013: 389723, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23971030

RESUMEN

Vitamin B6 is one of the most versatile cofactors in plants and an essential phytonutrient in the human diet that benefits a variety of human health aspects. Although biosynthesis of the vitamin has been well resolved in recent years, the main research is currently based on Arabidopsis thaliana with very little work done on major crop plants. Here we provide the first report on interactions and expression profiles of PDX genes for vitamin B6 biosynthesis in potato and how vitamin B6 content varies in tubers of different genotypes. The results demonstrate that potato is an excellent resource for this vitamin and that strong natural variation in vitamin B6 content among the tested cultivars indicates high potential to fortify vitamin B6 nutrition in potato-based foods.


Asunto(s)
Regulación de la Expresión Génica de las Plantas/fisiología , Familia de Multigenes/fisiología , Transferasas de Grupos Nitrogenados/fisiología , Solanum tuberosum/genética , Solanum tuberosum/metabolismo , Vitamina B 6/fisiología , Genotipo , Solanum tuberosum/clasificación , Especificidad de la Especie
7.
Nutr Rev ; 71(4): 239-44, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23550784

RESUMEN

A variety of inflammatory disease conditions have been found to be associated with low levels of plasma pyridoxal 5'-phosphate (PLP), the active form of vitamin B6 , without any indication of a lower dietary intake of vitamin B6 , excessive catabolism of the vitamin, or congenital defects in its metabolism. The present review was conducted to examine the existing literature in this regard. Current evidence suggests that the inverse association between plasma PLP and inflammation may be the result of mobilization of this coenzyme to the site of inflammation, for use by the PLP-dependent enzymes of the kynurenine pathway of tryptophan degradation, metabolism of the immunomodulatory sphingolipids, ceramide and sphingosine 1-phosphate, and for serine hydroxymethylase for immune cell proliferation.


Asunto(s)
Inflamación/sangre , Fosfato de Piridoxal , Deficiencia de Vitamina B/complicaciones , Biomarcadores/sangre , Humanos , Inflamación/epidemiología , Inflamación/etiología , Mediadores de Inflamación/sangre , Fosfato de Piridoxal/sangre , Fosfato de Piridoxal/deficiencia , Fosfato de Piridoxal/fisiología , Vitamina B 6/sangre , Vitamina B 6/metabolismo , Vitamina B 6/fisiología , Deficiencia de Vitamina B/sangre
8.
Neurochem Int ; 62(3): 324-9, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23306210

RESUMEN

Depression is characterized by sadness, purposelessness, irritability, and impaired body functions. Depression causes severe symptoms for several weeks, and dysthymia, which may cause chronic, low-grade symptoms. Treatment of depression involves psychotherapy, medications, or phototherapy. Clinical and experimental evidence indicates that an appropriate diet can reduce symptoms of depression. The neurotransmitter, serotonin (5-HT), synthesized in the brain, plays an important role in mood alleviation, satiety, and sleep regulation. Although certain fruits and vegetables are rich in 5-HT, it is not easily accessible to the CNS due to blood brain barrier. However the serotonin precursor, tryptophan, can readily pass through the blood brain barrier. Tryptophan is converted to 5-HT by tryptophan hydroxylase and 5-HTP decarboxylase, respectively, in the presence of pyridoxal phosphate, derived from vitamin B(6). Hence diets poor in tryptophan may induce depression as this essential amino acid is not naturally abundant even in protein-rich foods. Tryptophan-rich diet is important in patients susceptible to depression such as certain females during pre and postmenstrual phase, post-traumatic stress disorder, chronic pain, cancer, epilepsy, Parkinson's disease, Alzheimer's disease, schizophrenia, and drug addiction. Carbohydrate-rich diet triggers insulin response to enhance the bioavailability of tryptophan in the CNS which is responsible for increased craving of carbohydrate diets. Although serotonin reuptake inhibitors (SSRIs) are prescribed to obese patients with depressive symptoms, these agents are incapable of precisely regulating the CNS serotonin and may cause life-threatening adverse effects in the presence of monoamine oxidase inhibitors. However, CNS serotonin synthesis can be controlled by proper intake of tryptophan-rich diet. This report highlights the clinical significance of tryptophan-rich diet and vitamin B(6) to boost serotonergic neurotransmission in depression observed in various neurodegenerative diseases. However pharmacological interventions to modulate serotonergic neurotransmission in depression, remains clinically significant. Depression may involve several other molecular mechanisms as discussed briefly in this report.


Asunto(s)
Depresión/metabolismo , Dieta , Serotonina/fisiología , Transmisión Sináptica , Depresión/fisiopatología , Epilepsia/metabolismo , Epilepsia/fisiopatología , Humanos , Enfermedad de Parkinson/metabolismo , Enfermedad de Parkinson/fisiopatología , Trastorno Afectivo Estacional/metabolismo , Trastorno Afectivo Estacional/terapia , Vitamina B 6/fisiología
9.
Subcell Biochem ; 56: 247-64, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22116703

RESUMEN

Epidemiologic and laboratory animal studies have suggested that the availability of vitamin B6 modulates cancer risk. The means by which B6 mediates this effect is not known with any surety but it has been reported that high dietary vitamin B6 attenuates and low dietary vitamin B6 increases the risk of cancer. In fact vitamin B6 is widely distributed in foods and overt deficiency of this vitamin is not common. Nevertheless, marginal or secondary vitamin B6 deficiency, which might have an adverse effect on carcinogenesis, is rather common especially among old adults and alcoholics. This chapter addressed currently available information regarding the relationship between vitamin B6 and cancer.


Asunto(s)
Neoplasias/epidemiología , Deficiencia de Vitamina B 6/epidemiología , Vitamina B 6/fisiología , Adulto , Anciano , Anciano de 80 o más Años , Animales , Humanos , Transducción de Señal , Vitamina B 6/administración & dosificación
10.
Subcell Biochem ; 56: 265-90, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22116704

RESUMEN

While overt vitamin B6 deficiency is not a frequent finding nowadays in medical practice, evidence suggests that insufficiency of this vitamin is rather widespread in a quite large portion of the population such as the elderly or in not unusual conditions such as that of alcohol addiction. Moreover, a mild deficiency in B6 vitamin is a state that may be associated with an increased risk of cardiovascular disease. Epidemiologic evidence from case control and prospective studies have suggested that low dietary intake or reduced blood concentrations of vitamin B6 is associated with an increased risk of cardiovascular disease, although most recent trials demonstrated the ineffectiveness of vitamin B6 supplementation on the prevention of cardiovascular events recurrence. Due to limited and somewhat inconsistent data together with the ample variety of critical functions in which vitamin B6 is involved in the human body, it is very challenging to attempt at establishing a cause and effect relationship between vitamin B6 and risk of cardiovascular disease as it is to delineate the exact mechanism(s) by which vitamin B6 may modulate such risk. In the present chapter we review the currently available knowledge deriving from both epidemiological and mechanistic studies designed to define potential candidate mechanisms for the association of vitamin B6 impairment and risk of cardiovascular disease development.


Asunto(s)
Enfermedades Cardiovasculares/epidemiología , Deficiencia de Vitamina B 6/epidemiología , Vitamina B 6/fisiología , Animales , Coagulación Sanguínea/efectos de los fármacos , Coagulación Sanguínea/fisiología , Humanos , Sistema Inmunológico/efectos de los fármacos , Sistema Inmunológico/fisiología , Inflamación/etiología , Metabolismo de los Lípidos/efectos de los fármacos , Factores de Riesgo , Vitamina B 6/farmacología , Vitamina B 6/uso terapéutico
11.
Subcell Biochem ; 56: 291-300, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22116705

RESUMEN

Endogenous reactive intermediates such as photoexcited states of tissue chromophores, reactive oxygen species (ROS), reactive carbonyl species (RCS), and transition metal ions are mediators of tissue damage involved in initiation and progression of human pathologies including tumorigenesis, atherosclerosis, diabetes, and neurodegenerative disease. A large body of evidence now suggests that B6 vitamers antagonize the harmful activity of endogenous reactive intermediates fulfilling a very different role than that established as a cofactor for numerous enzymes. In this chapter, the structural basis of vitamin B6 activity as a potent antioxidant, metal chelator, carbonyl scavenger, and photosensitizer is presented and the physiological relevance is discussed.


Asunto(s)
Coenzimas/fisiología , Vitamina B 6/fisiología , Animales , Antioxidantes/farmacología , Antioxidantes/fisiología , Quelantes/farmacología , Coenzimas/farmacología , Depuradores de Radicales Libres/farmacología , Humanos , Fármacos Fotosensibilizantes/farmacología , Piridoxamina/farmacología , Piel/metabolismo , Piel/efectos de la radiación , Vitamina B 6/farmacología
12.
Bull Cancer ; 98(10): 1201-8, 2011 Oct.
Artículo en Francés | MEDLINE | ID: mdl-22001823

RESUMEN

Vitamin B6 is well-known for its role as a cofactor in many enzymatic reactions and recently, several epidemiological studies have highlighted the importance of this vitamin as a protective agent against various cancers: elevated vitamin B6 plasma levels were associated with a lower risk of colorectal cancer development, for example. In vivo studies have shown that vitamin B6 decreased cell proliferation and enhanced the immune response. At the cellular level, antioxidant, pro-apoptotic and anti-angiogenic effects have been identified. At the molecular level, vitamin B6 is able to inhibit the transactivation potential of various nuclear receptors. Interestingly, a recent paper has described the conjugation of vitamin B6 to RIP140 (receptor interacting protein of 140 kDa), a protein that acts as a transcriptional corepressor of nuclear receptors. This post-translational modification increases the transcriptional repression of RIP140 and regulates its subcellular localization and its ability to interact with different protein partners. Finally, vitamin B6 is involved in the methyl donor cycle ant thus, some of the antitumor properties of vitamin B6 may involve an indirect effect on the level of DNA or histone methylation. All of these mechanistic and clinical data justify further studies to decipher the mechanism of action of vitamin B6 and its clinical interest in combination with molecules typically used in chemotherapy or hormonal therapy.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/metabolismo , Proteínas de Neoplasias/metabolismo , Neoplasias/prevención & control , Proteínas Nucleares/metabolismo , Vitamina B 6/fisiología , Animales , Neoplasias Colorrectales/metabolismo , Neoplasias Colorrectales/prevención & control , Metilación de ADN/fisiología , Epigénesis Genética/fisiología , Histonas/metabolismo , Humanos , Neoplasias/metabolismo , Proteína de Interacción con Receptores Nucleares 1 , Procesamiento Proteico-Postraduccional , Ratas , Receptores Citoplasmáticos y Nucleares/metabolismo
14.
Nutr Rev ; 68 Suppl 2: S112-8, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21091944

RESUMEN

Deficiencies of the vitamins folate, B(12) , and B(6) are associated with neurological and psychological dysfunction and with congenital defects. In the elderly, cognitive impairment and incident dementia may be related to the high prevalence of inadequate B vitamin status and to elevations of plasma homocysteine. Plausible mechanisms include homocysteine neurotoxicity, vasotoxicity, and impaired S-adenosylmethionine-dependent methylation reactions vital to central nervous system function. In light of this, it is imperative to find safe ways of improving vitamin B status in the elderly without exposing some individuals to undue risk.


Asunto(s)
Envejecimiento/fisiología , Encéfalo/fisiología , Trastornos del Conocimiento/etiología , Deficiencia de Vitamina B 12/complicaciones , Deficiencia de Vitamina B 6/complicaciones , Anciano , Encéfalo/efectos de los fármacos , Trastornos del Conocimiento/prevención & control , Homocisteína/sangre , Humanos , Estado Nutricional , Vitamina B 12/administración & dosificación , Vitamina B 12/fisiología , Deficiencia de Vitamina B 12/metabolismo , Vitamina B 6/administración & dosificación , Vitamina B 6/fisiología , Deficiencia de Vitamina B 6/metabolismo , Complejo Vitamínico B/administración & dosificación , Complejo Vitamínico B/fisiología
15.
J Biochem ; 147(4): 451-7, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20353954

RESUMEN

Esmond E. Snell (1914-2003) was a giant of B-vitamin and enzyme research. His early research in bacterial nutrition had lead to the discovery of vitamins such as lipoic acid and folic acid, and an anti-vitamin avidin. He developed microbiological assay methods for riboflavin and other vitamins and amino acids, which are still used today. He also investigated the metabolism of vitamins, discovered pyridoxal and pyridoxamine as the active forms of vitamin B(6) and revealed the mechanism of transamination and other reactions catalysed by vitamin B(6) enzymes. His research in later years on pyruvoyl-dependent histidine decarboxylase unveiled the biogenesis mechanism of this first built-in cofactor. Throughout his career, he was a great mentor of many people, all of whom are inspired by his philosophy of science.


Asunto(s)
Coenzimas/historia , Complejo Vitamínico B/historia , Animales , Arthrobacter/enzimología , Arthrobacter/metabolismo , Bioquímica/historia , Coenzimas/aislamiento & purificación , Coenzimas/fisiología , Historia del Siglo XX , Humanos , Lactobacillus/enzimología , Lactobacillus/crecimiento & desarrollo , Lactobacillus/metabolismo , Técnicas Microbiológicas/historia , Ácido Pantoténico/aislamiento & purificación , Ácido Pantoténico/fisiología , Pseudomonas/enzimología , Pseudomonas/metabolismo , Saccharomyces/enzimología , Saccharomyces/crecimiento & desarrollo , Saccharomyces/metabolismo , Vitamina B 6/historia , Vitamina B 6/aislamiento & purificación , Vitamina B 6/fisiología , Complejo Vitamínico B/aislamiento & purificación , Complejo Vitamínico B/fisiología
16.
J Matern Fetal Neonatal Med ; 23(12): 1323-43, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20373888

RESUMEN

This two-part review highlights micronutrients for which either public health policy has been established or for which new evidence provides guidance as to recommended intakes during pregnancy. One pivotal micronutrient is folate, the generic name for different forms of a water-soluble vitamin essential for the synthesis of thymidylate and purines and, hence, DNA. For non-pregnant adult women the recommended intake is 400 µg/day dietary folate equivalent. For women capable of becoming pregnant an additional 400 µg/day of synthetic folic acid from supplements or fortified foods is recommended to reduce the risk of neural tube defects (NTD). The average amount of folic acid received through food fortification (grains) in the US is only 128 µg/day, emphasising the need for the supplemental vitamin for women of reproductive age. Vitamin B12 (cobalamin) is a cofactor required for enzyme reactions, including generation of methionine and tetrahydrofolate. B12 is found almost exclusively in foods of animal origin (meats, dairy products); therefore, vegetarians are at greatest risk for dietary vitamin B12 deficiency and should be supplemented. Vitamin B6 is required for many reactions, primarily in amino acid metabolism. Meat, fish and poultry are good dietary sources. Supplementation beyond routine prenatal vitamins is not recommended.


Asunto(s)
Dieta , Ácido Fólico/administración & dosificación , Necesidades Nutricionales , Reproducción/fisiología , Vitamina B 12/administración & dosificación , Vitamina B 6/administración & dosificación , Animales , Anomalías Congénitas/etiología , Productos Lácteos , Suplementos Dietéticos , Grano Comestible , Femenino , Peces , Ácido Fólico/fisiología , Ácido Fólico/toxicidad , Deficiencia de Ácido Fólico , Humanos , Carne , Política Nutricional , Aves de Corral , Embarazo , Vitamina B 12/fisiología , Vitamina B 12/toxicidad , Deficiencia de Vitamina B 12 , Vitamina B 6/fisiología , Vitamina B 6/toxicidad , Deficiencia de Vitamina B 6
17.
Hum Reprod Update ; 16(1): 80-95, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-19567449

RESUMEN

BACKGROUND: Micronutrient deficiencies have been associated with significantly high reproductive risks, ranging from infertility to fetal structural defects and long-term diseases. In this review we focus on the reproductive risks related to some micronutrients during the periconceptional period, a critical step in determining fetal development and health due to the potential onset of several disorders. METHODS: Embase Medline and PubMed databases, Google-indexed scientific literature and periodics from on-line University of Milan Bibliotecary Service were searched to identify relevant publications. In vivo human studies were mainly searched for, but when needed animal studies as well as in vitro and cell culture experiments were also considered. RESULTS: Fertility, conception, implantation, fetal organogenesis and placentation are the critical stages potentially affected by nutrition during the periconceptional period. Reactive oxygen species (ROS) and total homocysteine (tHcy) plasma levels are factors involved in the respective mechanisms. The preconceptional period is particularly important since it affects both fertility and the early stages of gestation. Micronutrients' dietary intake and maternal status affect the different phases of the onset and development of pregnancy as well as of the conceptus. CONCLUSION: Although human studies are scarce, and conclusive evidence is provided solely for periconceptional folate and prevention of neural tube defects (NTDs), the overall data indicate that micronutrients may affects fertility, embryogenesis and placentation, and the prophylactic use of some micronutrients may be useful in preventing several adverse pregnancy outcomes. Efforts to increase awareness of a healthy diet should be strengthened not only throughout pregnancy but also before. However, further researches in humans are necessary to optimise periconceptional micronutrient requirements.


Asunto(s)
Desarrollo Embrionario/fisiología , Micronutrientes/fisiología , Antioxidantes/fisiología , Cobre/fisiología , Dieta , Femenino , Fertilización , Ácido Fólico/fisiología , Humanos , Hierro/fisiología , Micronutrientes/deficiencia , Embarazo , Resultado del Embarazo , Factores de Riesgo , Factores de Tiempo , Vitamina A/fisiología , Vitamina B 12/fisiología , Vitamina B 6/fisiología , Zinc/fisiología
18.
Food Nutr Bull ; 29(2 Suppl): S5-16; discussion S17-9, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18709878

RESUMEN

This paper provides a general review on folate and vitamin B12 nutrition and metabolism and the metabolic interrelationship between these vitamins. The effects of some common polymorphisms in folate and vitamin B12 genes and the influence of vitamin B6 and riboflavin status on folate and vitamin B12 metabolism are also discussed.


Asunto(s)
Ácido Fólico/metabolismo , Polimorfismo Genético , Riboflavina/fisiología , Vitamina B 12/metabolismo , Vitamina B 6/fisiología , Disponibilidad Biológica , Ácido Fólico/genética , Ácido Fólico/farmacocinética , Humanos , Absorción Intestinal , Riboflavina/metabolismo , Vitamina B 12/genética , Vitamina B 12/farmacocinética , Vitamina B 6/metabolismo
19.
J Antimicrob Chemother ; 61(2): 421-4, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18174198

RESUMEN

BACKGROUND: Linezolid is the first approved synthetic oxazolidinone with activity against multidrug-resistant gram-positive pathogens. However, haematological toxic effects of linezolid frequently limit its prolonged use, especially in patients with poor marrow reserves such as those with cancer receiving chemotherapy. Previous authors have reported that administration of vitamin B6 with linezolid reversed pancytopenia in two patients. METHODS: This is an open-label study of 31 patients with cancer who received linezolid at 600 mg twice daily and vitamin B6 at 50 mg/day for at least 2 weeks mean therapy duration and they were matched to 62 control patients who received linezolid without vitamin B6 to determine whether the concomitant use of vitamin B6 attenuates the haematological toxicity of linezolid in patients with cancer. RESULTS: Patients were matched according to age, underlying disease, duration of therapy, creatinine level and use of chemotherapy. We found no significant differences in the rate of haematological toxic effects between the two patient groups. The rate of thrombocytopenia was 13% in the vitamin B6 group and 15% in the control group (P = 0.82). Also, the rate of leucopenia was 7% versus 5%, respectively (P = 0.75). None of the patients in the vitamin B6 group had anaemia compared with 5% in the control group. CONCLUSIONS: Vitamin B6 given at 50 mg/day may have an impact on anaemia but did not prevent linezolid-induced thrombocytopenia or leucopenia in cancer patients.


Asunto(s)
Acetamidas/efectos adversos , Enfermedades Hematológicas/prevención & control , Neoplasias/tratamiento farmacológico , Oxazolidinonas/efectos adversos , Vitamina B 6/uso terapéutico , Acetamidas/toxicidad , Adulto , Anciano , Femenino , Enfermedades Hematológicas/etiología , Humanos , Linezolid , Masculino , Persona de Mediana Edad , Neoplasias/complicaciones , Oxazolidinonas/toxicidad , Vitamina B 6/fisiología
20.
Am J Psychiatry ; 164(6): 861-7, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17541043

RESUMEN

High levels of homocysteine are associated with cerebrovascular disease, monoamine neurotransmitters, and depression of mood. A plausible hypothesis for these associations is that high homocysteine levels cause cerebral vascular disease and neurotransmitter deficiency, which cause depression of mood. The homocysteine depression hypothesis, if true, would mandate inclusions of imaging studies for cerebrovascular disease and measures of homocysteine, folate, and B12 and B6 vitamins in the clinical evaluation of older depressed patients. Longitudinal studies and clinical trials should be designed to challenge the hypothesis.


Asunto(s)
Trastorno Depresivo/fisiopatología , Homocisteína/fisiología , Factores de Edad , Anciano , Anciano de 80 o más Años , Enfermedades Cardiovasculares/epidemiología , Niño , Comorbilidad , Trastorno Depresivo/sangre , Trastorno Depresivo/epidemiología , Femenino , Ácido Fólico/metabolismo , Ácido Fólico/fisiología , Homocisteína/sangre , Humanos , Hiperhomocisteinemia/epidemiología , Hiperhomocisteinemia/fisiopatología , Masculino , Mutación/genética , Neurotransmisores/metabolismo , Neurotransmisores/fisiología , Accidente Cerebrovascular , Vitamina B 12/metabolismo , Vitamina B 12/fisiología , Vitamina B 6/metabolismo , Vitamina B 6/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA